Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Barbara Niederoest"'
Autor:
Viktor von Wyl, Sara Gianella, Marek Fischer, Barbara Niederoest, Herbert Kuster, Manuel Battegay, Enos Bernasconi, Matthias Cavassini, Andri Rauch, Bernard Hirschel, Pietro Vernazza, Rainer Weber, Beda Joos, Huldrych F Günthard, Swiss HIV Cohort Study-SHCS
Publikováno v:
PLoS ONE, Vol 6, Iss 11, p e27463 (2011)
BACKGROUND: Long-term benefits of combination antiretroviral therapy (cART) initiation during primary HIV-1 infection are debated. METHODS: The evolution of plasma HIV-RNA (432 measurements) and cell-associated HIV-DNA (325 measurements) after cessat
Externí odkaz:
https://doaj.org/article/e0d2be8073d84a5d8ebfd91ebbd937f0
Publikováno v:
Advanced Healthcare Materials. 12:2370031
Autor:
Luc Dupuis, Barbara Niederoest, Jean-Philippe Loeffler, Dana A. Dodd, Martin E. Schwab, Stefan Bloechlinger
Publikováno v:
Journal of Biological Chemistry. 280:12494-12502
Nogo-A, -B, and -C are generated from the Nogo/RTN-4 gene and share a highly conserved C-terminal domain. They lack an N-terminal signal sequence and are predominantly localized to the endoplasmic reticulum (ER). We found the N terminus of endogenous
Autor:
Sara Gianella, Bernard Hirschel, Andri Rauch, Matthias Cavassini, Enos Bernasconi, Manuel Battegay, Barbara Niederoest, Viktor von Wyl, Beda Joos, Huldrych F. Günthard, Herbert Kuster, Swiss Hiv Cohort Study-SHCS, Marek Fischer, Pietro Vernazza, Rainer Weber
Publikováno v:
PLoS ONE, Vol 6, Iss 11, p e27463 (2011)
Wyl, Viktor von; Gianella, Sara; Fischer, Marek; Niederoest, Barbara; Kuster, Herbert; Battegay, Manuel; et al.(2011). Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption.. PloS one, 6(11), e27463. doi: 10.1371/journal.pone.0027463. UC Office of the President: Research Grants Program Office (RGPO). Retrieved from: http://www.escholarship.org/uc/item/6c70z38x
Plos One, vol. 6, no. 11, pp. e27463
PloS one, vol 6, iss 11
Wyl, Viktor von; Gianella, Sara; Fischer, Marek; Niederoest, Barbara; Kuster, Herbert; Battegay, Manuel; Bernasconi, Enos; Cavassini, Matthias; Rauch, Andri; Hirschel, Bernard; Vernazza, Pietro; Weber, Rainer; Joos, Beda; Günthard, Huldrych F; Swiss HIV Cohort Study-SHCS, (2011). Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption. PLoS ONE, 6(11), e27463. Lawrence, Kans.: Public Library of Science 10.1371/journal.pone.0027463
PLoS ONE
PloS one
Wyl, Viktor von; Gianella, Sara; Fischer, Marek; Niederoest, Barbara; Kuster, Herbert; Battegay, Manuel; et al.(2011). Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption.. PloS one, 6(11), e27463. doi: 10.1371/journal.pone.0027463. UC Office of the President: Research Grants Program Office (RGPO). Retrieved from: http://www.escholarship.org/uc/item/6c70z38x
Plos One, vol. 6, no. 11, pp. e27463
PloS one, vol 6, iss 11
Wyl, Viktor von; Gianella, Sara; Fischer, Marek; Niederoest, Barbara; Kuster, Herbert; Battegay, Manuel; Bernasconi, Enos; Cavassini, Matthias; Rauch, Andri; Hirschel, Bernard; Vernazza, Pietro; Weber, Rainer; Joos, Beda; Günthard, Huldrych F; Swiss HIV Cohort Study-SHCS, (2011). Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption. PLoS ONE, 6(11), e27463. Lawrence, Kans.: Public Library of Science 10.1371/journal.pone.0027463
PLoS ONE
PloS one
Background: Long-term benefits of combination antiretroviral therapy (cART) initiation during primary HIV-1 infection are debated. Methods: The evolution of plasma HIV-RNA (432 measurements) and cell-associated HIV-DNA (325 measurements) after cessat